The tie gene encodes a receptor tyrosine kinase that is expressed in the endothelium of blood vessels, particularly during embryonic development and angiogenesis in adults. We have cloned and characterized the mouse tie gene and isolated the human and mouse tie promoters. The promoter activities of human and mouse tie were analyzed using luciferase reporter gene constructs in transfected cell lines and &galactosidase constructs in transgenic mice. In transfection assays of cultured cells, both human and mouse promoter DNA fragments showed activity that was not restricted to endothelial cells. in contrast, in transgenic mice both promoters directed expression of the reporter gene to HE CIRCULATORY system is the first organ system to differentiate in the developing embryo.' Under the influence of the endoderm, the extraembryonic and embryonic mesodermal cells differentiate into hemangioblasts and angioblasts, which give rise to blood and endothelial cells.' Embryonic and yolk sac vascular systems amalgate in 8.5-day post coitum (pc) mouse embryos, and a day later, the heart beats regularly, circulating primitive blood cells, nutrients, and metabolic waste products. Endothelial cells covering blood vessels provide a selective barrier between blood and other tissues of the embryo. When organs differentiate and begin to perform their specific functions, the phenotypic heterogeneity of endothelial cells increases. Fenestrated vessels, nonfenestrated vessels with tight junctions, and sinusoidal vessels can be found, for example, in the kidney, brain, and liver, respectively. In addition, endothelial cells perform differentiated functions. In adult animals, they take part in several biochemical, physiologic, and pathologic processes such as blood cell trafficking, blood clotting and hemostasis, ovulation, wound healing, atherosclerosis, and angiogenesis associated with rheumatoid arthritis, diabetic retinopathy, and ne~plasia.'.~ At least five receptor tyrosine kinase genes are expressed in endothelial c e k 5 Of these, the protein products of the FLTI, KDWFLK-I, and FLT4 genes belong to receptor tyro- 
endothelial cells undergoing vasculogenesis and angiogenesis. In adult mice, tie promoter activity in lung and many vessels of the kidney was as high as in the vessels of the corresponding embryonic tissues, whereas in the heart, brain and liver, tie promoter activity was downregulated and restricted to coronaries. cusps, capillaries, and arteries. Our results show that the endothelial cell-type specificity of the tie promoter in vivo can be transferred to heterologous genes by using relatively short promoter fragments. The tie promoter, thus, has useful propertiesfor potential gene therapy.
0 1995 by The American Society of Hematology.
sine lunase subclass 111, and tie and its close relative tek (tie-2) form a novel subclass of their OW^.^"^ Our group and others have cloned both the human and mouse tie cDNAs,'~.'" and homologous cDNAs have been isolated from bovine and rat sources.2',22
The 4.4-kb tie mRNA encodes a 130-kD transmembrane protein that is N-glycosylated. In its extracellular domain, tie contains two immunoglobulin homology (IGH) domains and three epidermal growth factor and fibronectin type 111 homology domains (EGFH and FNIII, respectively), followed by trans-and juxtamembrane domains connected to the tyrosine kinase domain, which is split by a short kinase insert, and a carboxyl terminal Both tie and tek have been localized to mouse chromosome 4 at a distance of 12.2 centiMorgans (CM) from each other.zz These receptors are uniformly expressed in endothelial cells of different blood vessels during embryonic development, although the expression of tek mRNA in extraembryonic tissues seems to begin on day 7.5 pc, half a day earlier than the expression of t i c z 3 In adult mice, tie mRNA persists in vessels of the lung, whereas in the heart and brain, it appears to decrease." We have found that tie mRNA is enhanced during angiogenesis associated with ovulation and wound healing and in human glioblastomas and metastatic melanoma^.'^^^^^^^ To better understand the regulation of tie expression, we have cloned and characterized genomic clones for mouse tie and both mouse and human tie promoter regions. We found that tie promoter fragments are active in cultured cells, although they lack endothelial cell specificity. In transgenic mice, the activity of promoter fragments was restricted to endothelium and occasional hematopoietic cells during embryonic development starting from day 8.5 pc. Both human and mouse tie promoters were active in many types of vessels, eg, in dorsal aorta, vitelline vein, capillaries, and arteries and in the endocardium of the heart, where fie mRNA has been l o~a l i z e d . '~.~~ In the adult mouse, the tie promoter showed activity in heart, brain, and liver, with the highest expression occurring in the cusps and coronaries of the heart and disappearing gradually after development from the endocardium of the heart, brain vessels, and the hepatic veins.
MATERIALS AND METHODS
Cloning and characterization of the genomic structure of tie. TO characterize the genomic organization of the mouse tie gene, we screened approximately 3 X IO6 plaques from a genomic library made from DNA of adult 129SV mouse liver (Stratagene, La Jolla, CA) using the mouse tie cDNA fragment lClD," encoding the EGFH domains, as a probe. Three separate clones were obtained, and they were subcloned into pGEM3Zf(+) (Promega, Madison, WI) and characterized by restriction endonuclease cleavage analysis and dideoxy chain termination sequencing. The lengths of the introns were determined by sequencing (short introns), analysis of the lengths of restriction fragments, or estimation from the sizes of products of interexonic polymerase chain reaction (PCR) amplification.
GT-repeat Alu
Three human tie clones were isolated from a human placental genomic DNA library in the EMBL-3 vector (Clontech, Palo Alto, CA) using a PCR fragment containing the nucleotides encoding tie signal sequence (primers: 5'-CCCACATGAGAAGCC-3' and 5'-TGAGATCTGGAGTATGGTCTGGCGGGTGCCC-3') as a probe.
Construction of plasmids. The tie promoterhuciferase gene constructs were generated by subcloning the 5'-flanking, 735-bp Afr IIApa I mouse genomic DNA fragment, blunted with the Klenow enzyme, to the blunted Xho I site of the basic pGL2 vector (Stratagene).26 The human 3-kb EcoRI-AlwNI promoter fragment was blunt-end cloned to the Hindu1 site of pGL2. For experiments in transgenic mice, the same mouse DNA fragment was blunt-end ligated to the blunted unique Hind111 site of the SDK-LacZ-pSK Bluescript The 5-kb AlwNI fragment of the human tie promoter was similarly blunt-end ligated to the same vector (see Fig 1,  I1 B tetra-acetic acid, 10% glycerol, 1% Triton X-100).
For the normalization of the luciferase values relative to the transfection efficiency, the copy number of the pGL2 reporter gene was determined." After three freeze-thaw cycles, about 50 pL of the lysates was centrifuged, and the supernatants were collected and stored at 70°C until assayed. Aliquots of the supernatants (5 and 10 pL) and known amounts of the reporter gene, used as a standard, were mixed with 200 pL of 2 X saline sodium citrate (SSC), heated for 5 minutes at 95°C. and spotted on nylon filters. The filters were dried and autoradiographed, and the radioactive spots were measured in a liquid scintillation counter. Then, the filter was hybridized with the pGL2 probe, washed, and exposed to film. Radioactive spots were identified and counted in a scintillation counter.
The luciferase assay was performed according to the manufacturer's protocol (Promega). Appropriate amounts of cell lysate corresponding to 4 X lo8 plasmid copies were incubated with 100 pL of reaction mixture, and a luminometer (Bio-Orbit 1253; Bio-Orbit, Turku, Finland) was used to measure the light intensity of the reaction.
Production of transgenic mice. The transgene was separated from the vector by digestion with Sal I, purified by electrophoresis through an agarose gel, and recovered by absorption to glass beads (Bio 101, La Jolla, CA) according to the manufacturer's recommendations. Transgenic mice were produced by the microinjection techn i q~e .~' Zygotes for microinjections were obtained from superovulated (BALBk X DBAI2)Fl hybrid female mice (CD2F1) mated with CD2F1 males. After microinjections, the zygotes were transferred at one-or two-cell stage into oviducts of pseudopregnant foster mothers (CD2Fl mice).
Tail samples were taken from the pups at the age of 3 weeks, and DNA was isolated by the salt precipitation method." PCR was used to identify the transgenic offspring using mouse promoter-specific primer (5'-CTATTGAGAAGGT"ITGGAGGC-3') and lacZ vector primer (5'-GCTCTAGAACTAGTGGATC-3') or human promoterspecific primer (5'-GAGACAGGGGATGGGAAAAA-3') and lac2 vector primer (5'-GAAGATCGCACTCCAGCCAG-3'). Also, sections from the tails of the mice were stained for 8-galactosidase activity. Transgenic 8-week-old males were bred with wild-type NMRI females, and the age of the embryos was estimated according to the formation of the copulation plug on day 0.5.
8-galactosidase staining of tissues. Whole embryos or small pieces of adult tissues were transferred into 4% paraformaldehyde in PBS, pH 7.4, and incubated at 4°C for 20 minutes with gentle agitation.'3 The tissues were then washed in PBS and incubated in freshly prepared X-Gal reaction mixture (1 mglmL 4-chloro-5-bromo-3-indolyl-P-galactoside, 4 mmol/L &Fe(CN), X 3H20, 4 mmol/L K,Fe(CN),, 2 mmoVL MgC12 in PBS) at 30°C for 1 to 2 days, washed again in PBS for 5 hours, and transferred to 30% sucrose for cryopreservation and storage. The samples were embedded in Tissue-Tek (Miles, Naperville, IL), and 15-pm sections were cut on silane-treated slides. The sections were postfixed in 4% paraformaldehyde for 5 minutes and washed twice in PBS and once in distilled water. Nuclear fast red was used as a counterstain.
RESULTS
Genomic structure of the mouse tie gene. A schematic structure of the mouse tie gene is shown in Fig 1A. Restriction mapping, PCR, and partial nucleotide sequence analysis showed that the tie gene spans approximately 18.5 kb of genomic DNA. As previously reported," the coding region of the tie gene is encoded by 23 exons. The distinct structural domains of the extracellular part of tie are encoded by either one exon (eg, the first IGH domain, EGFH domains 1 to 3, and FNIII domains 2 and 3) or two exons (eg, the second IGH domain and the FNIII domain 1). Also, the transmembrane region is encoded by a distinct exon, whereas the tyrosine kinase domain containing the kinase insert is encoded by altogether eight exons, the first of which contains the juxtamembrane region. The comparison of cDNA and genomic sequences showed that the 3' terminus of the mouse tie gene has an AATAAA polyadenylation signal 14 nucleotides (nt) upstream of the polyA addition site. The lengths of the introns varied from 80 bp to 2.6 kb ( Fig 1A) .
Comparison of mouse and human tie promoter sequences. Fig IB) . There was no corresponding sequence in the 5-kb AlwNI fragment of the human tie promoter shown in Fig 1C. The KG-l homologous region and sequences upstream of it were excluded in further analysis of the mouse promoter.
The human and mouse sequences shown in Fig 1 A contain several transcriptional initiation sites (I.L., unpublished data, June 1995). Upstream of the translation initiation site, they are 8 1 % identical for the first 148 nt, followed by a stretch of 95 nt of 33% identity, and further upstream, again a 71 % conserved region of 214 nt flanked by a 5' GT repeat sequence (Fig 2) . Of interest are two conserved doublets of consensus binding sites for the PEA3 transcription factor complex as well as a putative ets-l transcription factor binding site. A putative conserved AP-2 consensus binding site is also indicated. A GT repeat was found also in the human tie promoter, although further upstream.
Activity of putative tie promoter in cultured cells. For analysis of tie promoter activity in cultured cells, tie promoter-luciferase reporter constructs were transfected into LE-I1 endothelial or HeLa cervical carcinoma cells together with a control plasmid, and the promoter activity was determined. The activities obtained were compared with the promoter activity of RSV-luc, which was used as a positive control. Figure 3 shows the reporter values obtained, normalized to the intracellular copy number of the transfected plasmid. As can be seen from the figure, both 735-bp mouse A$ 11-Apa I and 3-kb human EcoRI-AlwNI promoter fragments yielded 6% to 15% of the activity obtained with the strong RSV promoter in LE-I1 and HeLa cells. In inverse orientation, the fragments showed very little activity in comparison with the empty vector (data not shown). The tie promoter was also active in MK-2 mouse keratinocyte and K562 human leukemia cell lines, confirming a lack of endothelial cell-specific expression (data not shown).
Activity of tie promoter in transgenic mice during embryonic development.
To study the possible endothelial cell specificity and developmental regulation of tie promoter activity, promoter-LacZ reporter vector fragments containing either the 735-bp mouse AJI 11-Apa I or 5-kb human AlwNI fragment were injected into fertilized mouse oocytes. Three transgenic founder mice were obtained with both of these constructs. Transgenic males were mated with wild-type females, and the offspring (86 transgenic mice for the 735-bp fragment and 47 for the 5-kb fragment) were analyzed on days 7.5 to 17.5 of development. The embryos showed a slight variation in the intensity of the reporter-encoded Pgalactosidase reaction color. No staining was seen in 7.5-day pc embryos, whereas in 8-to 8.5-day pc embryos (four to five somite stage), endothelial cells of the dorsal aorta and forming heart were strongly positive ( Fig  4A) . Certain cells of the head mesenchyme, presumably differentiating angioblasts, showed a ,&galactosidase signal, and the extraembryonic tissues, such as vitelline arteries and blood islands of the yolk sac, contained P-galactosidase-positive endothelial cells (Fig 5) . A few forming blood cells of the blood islands were also stained. A considerably reduced level of staining was evident in endothelial cells of day 12.5 pc blood islands.
The complexity of the vascular system increases rapidly during development, and in whole-mount, 9.5-day pc embryos, tie promoter activity was seen in the above-mentioned vessels as well as in the intersomitic arteries and the carotid (Fig 4B) . The prominent capillary network was also blue, eg, in the head. Intense staining was seen within the developing ventricles of the heart. In 10.5-day pc embryos, the capillary system is well-developed, and, therefore, the staining associated with large vessels of the embryo and the endocardium was only faintly discerned through the dense network of blue-stained capillaries (Fig 4C) . A wild-type embryo did not show any staining (Fig 4D) .
Details of the vascular system were further visualized by high magnification analysis of tissue sections of day-11 S , -15.5, and -17.5 pc embryos (Fig 6) . This staining pattern corresponds to the expression pattern obtained by in situ hybridization studies of fie mRNA.'* Very prominent pgalactosidase signals were observed in the interalveolar capillaries of the lung (Fig 6A) . In addition, the endocardium and myocardial vessels were positive in the heart (Fig 6, B and C). The tie promoter was also active in the vessels of the meninges and within the brain (Fig 6D) . Particularly intense P-galactosidase staining was obtained in the glomeruli of the kidney and in some vessels between kidney tubuli (Fig 6E) . In the liver, a faint signal was seen in the veins but not in the sinusoidal endothelial cells (Fig 6F) . The most r C da L. 
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prominent signal in the liver was in the hepatic arteries. The bone marrow of a 17.5-day pc embryo showed an intense blue color in the vascular network, although some P-galactosidase staining was also evident in clusters of unidentified cells (presumably hematopoietic cells; Fig 6G) . No significant differences were seen in the staining patterns obtained with mouse 735-bp and human 5-kb promoter fragments, although, in general, the signals from the 5-kb fragment were somewhat less prominent. tie promoter activity in adult mice. To determine whether the activity of the 735-bp promoter fragment correlates with the expression of tie mRNA in adult tissues as well, different tissues and organs of 8-week-old transgenic mice were stained. An intense blue staining was seen in endothelial cells of the lung (Fig 7A) . Interestingly, the endocardium of the heart was only faintly stained in comparison with the embryonic one (Fig 7B) . However, staining was seen in the cusps and chordae tendinae of the heart, as well as in the coronary vessels. In the cortical area of the brain, a few capillaries were weakly P-galactosidase-positive ( Fig  7C) . Kidney glomeruli and vessels surrounding the tubuli were also stained (Fig 7D) . Neither the large hepatic vessels nor the sinusoidal capillaries showed P-galactosidase activity in adult mice (Fig 7E) . Instead, small arteries surrounding the veins were positive. The staining pattern of adult bone marrow resembled the embryonic one (Fig 7F) . All these results are in agreement with the results of in situ hybridization of tie mRNA in the adult tissues, including downregulation of tie expression in certain tissues after de~elopment.'~
DISCUSSION
In this study we have further characterized the structure of the mouse tie receptor tyrosine kinase gene and both the mouse and human tie promoters. We show that the endothelial cell specificity of tie expression, including the downregulation seen after development, is reproduced by 5-kb and 735-bp upstream promoter fragments linked to a reporter gene in transgenic mice. In contrast, the activity of the same promoter fragments is not restricted to endothelial cells in culture. The blue reaction color from the P-galactosidase staining is located in the forming endocardium of the heart, and very faint color is distinguished in certain cells (presumably angioblasts, arrowheads) of the mesenchyme. Also, allantois is p-galactosidase-positive. (B) Forming endothelial cells of the blood islands are stained blue, although the intensity is decreased in 12.5-day pc blood islands (C). Endodermal cells are negative, and only few blood cells are P-galactosidase positive. a, allantois; e, endodermal cells; h, heart; m, mesenchyme; nt, neural tube. Arrowheads indicate P-galactosidasepositive cells in the mesenchyme, and arrows mark the endothelial cells in the blood islands. Scale bars: A and C, 0.1 mm; B, 0.05 mm. The mouse tie gene contains 23 exons,19 and the lengths of the introns vary from 80 bp to 2.6 kb. Overall, the tie gene spans about 19 kb of genomic DNA, including the endothelial cell-specific promoter elements. Although tie and tek genes encode closely similar endothelial receptor tyrosine kinases, tek expression in the extraembryonic tissues begins on day 7.5 pc, about half a day earlier than tie expression. In contrast to tek, tie mRNA is not detected in the amnion or in the sinusoidal vessels of the l i~e r . '~~~~~~'~~* * "
On the basis of their overall structure and expression pattern restricted to endothelia, it could be hypothesized that the tie and tek promoters resemble each other. However, the homology between the two promoters is very weak, although they have features in common with promoters of other receptor tyrosine kinases, eg, c-fms and fibroblast growth factor receptors 1 and 2.35-37 Both the tie and tek promoters lack typical TATA and CAAT boxes, and the tek promoter contains ets-1 and PEA3 consensus sites as well (Mira Puri, personal communication, June 1995; our unpublished observations, June 1995). However, recent studies show that the activity of the tek promoter, unlike tie, is shut off during embryonic de~elopment.3~" PEA3 sites may play an important role in the regulation of transcription of urokinase-type plasminogen activator (u-PA)?* ~tromelysin,3~ matrilysin,a and collagenase genes:' The protein products of these genes have been implicated in pericellular matrix degradation necessary for angiogenesis and tumor invasion. Interestingly, ets-l, like tie, is expressed in endothelial cells and downregulated in adult tissues, but induced again in the endothelium of tumor vessels and granulation tissue of wounds!* As shown here, the tie promoter is also downregulated in certain adult tissues, eg, in brain, heart, and liver. On the other hand, tie mRNA levels are enhanced during wound healing and during neovascularization of the ovary associated with hormone-induced corpus luteum formation." Furthermore, tie mRNA is upregulated in the vessels of glioblastomas in comparison with normal brain vasculaturex and in melanoma rnetastasi~.~~ We are currently analyzing the binding of different transcription factors to tie promoter. Further characterization of the tie promoter may provide us with valuable information on the regulatory mechanisms involved in angiogenesis and hematopoiesis.
Our sequence analysis shows that mouse genomic DNA approximately l kb upstream of the tie-coding region contains a putative exon from a gene related to previously discovered human KG-l cDNA. This human gene encodes a 3.7-kb mRNA containing a short open reading frame that may produce a secreted protein (Nobuo Nomura, personal communication, April 1994). The chromosomal localization of the mouse KG-l gene is not known, but in humans, this gene has been mapped to lq42, which is far from the tie locus in 1p33- 34.16 In vivo, both the mouse 735-bp and human 5-kb fragments of the tie promoter showed activity restricted to the endothelium. The reason for the activity of the tie promoter in all cultured cells despite its endothelial and hematopoietic cell specificity in vivo is not clear. One possibility is that the promoter is normally negatively regulated (suppressed) in tissues and that cultured cells lack this negative control. Such a control would also be relieved during the development of endothelial cells in vivo. Mechanisms operating through chromatin structure and genomic imprinting of regulatory sequences may also operate to restrict tie promoter expression in vivo. Alternatively, endothelial cells in vivo may contain specific factors and cultured cell lines, unspecific factors, which activate the tie promoter. Analysis of stable cell clones expressing tie promoterreporter constructs and comparison with cultured cells from tie promoter-LacZ transgenic mice may yield more insight into these mechanisms.
The 5-kb fragment gave a somewhat weaker expression of the reporter gene in vivo than the 735-bp fragment. This may be explained by a species specific difference when tested in mouse tissues. Alternatively, the activity of the human 5-kb promoter fragment may be reduced by mechanisms associated with chromatin structure, or negative elements may be present in this fragment. Both promoter fragments were active in endothelial cells of every organ undergoing vasculogenesis and angiogenesis during mouse development. In addition to endothelial cells, some of the blood cells of the yolk sac and the dorsal aorta were also weakly positive. So far, we do not know the identity of these cells, but we are currently characterizing the expression of tie and the activity of the tie promoter in hematopoietic cells. In adults, mouse tie promoter activity showed a similar spatial distribution to that of tie mRNA in in situ hybridizati~n.'*.'~ In certain tissues, eg, in lung and kidney, the promoter was as active as in the corresponding embryonic tissues. In heart endocardium, brain capillaries and veins, and sinusoidal capillaries of the liver, the P-galactosidase staining was barely detectable. Taken together, our data suggests that the 735-bp fragment contains the sequences essential for endothelial expression of tie during embryonic development and in adult tissues, but we cannot exclude the possibility that a region further upstream contains elements required for additional regulation of the tie gene.
The tie promoter is the first endothelial cell-specific promoter isolated and characterized that retains activity in adult mice. It provides a practical tool for gene delivery into endothelial cells in transgenic mice. Endothelial cells and the promoter elements controlling endothelial-specific gene expression may be useful in studies and eventual therapy for diseases involving the vascular system, eg, hemostasis, wound healing, atherosclerosis, diabetic retinopathy, rheumatoid arthritis, blood cell trafficking, inflammatory conditions, and tumor angiogenesis. Endothelial cells are in direct contact with blood and in close proximity with arterial smooth muscle cells and pericytes, and are, therefore, optimal for production and secretion of desired proteins into the bloodstream or for neighboring cells. Endothelial cells can also be transfected in vivo using vehicles such as liposomes and adenovirus and retrovirus vectors. The promoter activity of tie in capillaries, which form 99% of the vascular network, may prove useful for targeting genes into the endothelium and for the production of proteins into circulation.
